Background: Numerous studies have reported on the influence of diet on insulin resistance. Our study provides insight into the effect of germinated brown rice (GBR) and γ-aminobutyric acid (GABA) on early environment-driven programming and susceptibility to insulin resistance in rat offspring. Methods: Male rat offspring from female Sprague-Dawley rats fed with a high-fat diet (HFD) alone, HFD + GBR, or HFD + GABA extract throughout pregnancy and lactation were weaned 4 weeks after delivery and followed up for 8 weeks. A biochemical analysis and an assessment of the hepatic expression of insulin signaling genes were performed. Results: The results showed that intrauterine exposure to HFD caused metabolic perturbations in rat offspring which gravitated towards insulin resistance even though the rat offspring did not consume an HFD. GBR and GABA attenuated the HFD-induced changes by underlying regulation of the insulin signaling genes. Conclusions: The results suggest that intake of GBR and GABA during pregnancy and lactation can influence the programming of genes in rat offspring, thereby enhancing insulin sensitivity.

Keywords:
Epigenetics, Germinated brown rice, γ-Aminobutyric acid, Insulin resistance
1.
Minaiyan M, Ghannadi A, Movahedian A, Hakim-Elahi I: Effect of Hordeum vulgare L. (barley) on blood glucose levels of normal and STZ-induced diabetic rats. Res Pharm Sci 2014;9:173-178.
2.
Ludwig DS, Ebbeling CB: Type 2 diabetes mellitus in children: primary care and public health considerations. JAMA 2001;286:1427-1430.
3.
Duque-Guimarães DE, Ozanne SE: Nutritional programming of insulin resistance: causes and consequences. Trends Endocrinol Metab 2013;24:525-535.
4.
Khalaf G, Mohamed A-G: Effect of barley (Hordeum vulgare) on the liver of diabetic rats: histological and biochemical study. Egypt J Histol 2008;31:245-255.
5.
Imam MU, Ismail M, Ooi DJ, Sarega N, Ishaka A: Increased risk of insulin resistance in rat offsprings exposed prenatally to white rice. Mol Nutr Food Res 2015;59:180-184.
6.
Imam MU, Ismail M: Nutrigenomic effects of germinated brown rice and its bioactives on hepatic gluconeogenic genes in type 2 diabetic rats and HEPG2 cells. Mol Nutr Food Res 2013;57:401-411.
7.
Imam M, Azmi N, Bhanger M, Ismail N, Ismail M: Antidiabetic properties of germinated brown rice: a systematic review. Evid Based Complement Alternat Med 2012;2012:816501.
8.
Md Zamri ND, Imam MU, Abd Ghafar SA, Ismail M: Antioxidative effects of germinated brown rice-derived extracts on H2O2-induced oxidative stress in HepG2 cells. Evid Based Complement Alternat Med 2014;2014:371907.
9.
Martínez JA, Milagro FI, Claycombe KJ, Schalinske KL: Epigenetics in adipose tissue, obesity, weight loss, and diabetes. Adv Nutr 2014;5:71-81.
10.
Abdullah AB, Ito S, Adhana K: Estimate of rice consumption in Asian countries and the world towards 2050. Proceedings for Workshop and Conference on Rice in the World at Stake, 2006, Japan, Tottori University, pp 28-42. http://worldfood.apionet.or.jp/alias.pdf.
11.
Miñano FJ, Serrano J, Pascual J, Sancibrián M: Effects of GABA on gastric acid secretion and ulcer formation in rats. Life Sci 1987;41:1651-1658.
12.
Ly C, Yockell-Lelièvre J, Ferraro ZM, Arnason JT, Ferrier J, Gruslin A: The effects of dietary polyphenols on reproductive health and early development. Hum Reprod Update 2015;21:228-248.
13.
Ho J-N, Son M-E, Lim W-C, Lim S-T, Cho H-Y: Germinated brown rice extract inhibits adipogenesis through the down-regulation of adipogenic genes in 3T3-L1 adipocytes. Plant Foods Hum Nutr 2013;68:274-278.
14.
Batool S, Ahmed I, Sarwar M, ul Hassan H: Relationship of uric acid with superoxide dismutase (Sod) in induced hyperuricemic rat model. Pharmacol Pharm 2012;3:404-408.
15.
Draznin B: Molecular mechanisms of insulin resistance: serine phosphorylation of insulin receptor substrate-1 and increased expression of p85α: the two sides of a coin. Diabetes 2006;55:2392-2397.
16.
Bodhini D, Sandhiya M, Ghosh S, Majumder PP, Rao MS, Mohan V, Radha V: Association of His1085His INSR gene polymorphism with type 2 diabetes in South Indians. Diabetes Technol Ther 2012;14:696-700.
17.
Pessin JE, Saltiel AR: Signaling pathways in insulin action: molecular targets of insulin resistance. J Clin Invest 2000;106:165-169.
18.
Hotamisligil GS, Erbay E: Nutrient sensing and inflammation in metabolic diseases. Nat Rev Immunol 2008;8:923-934.
19.
De Luca C, Olefsky JM: Inflammation and insulin resistance. FEBS Lett 2008;582:97-105.
20.
Tilg H, Moschen AR: Inflammatory mechanisms in the regulation of insulin resistance. Mol Med 2008;14:222-231.
21.
Meshkani R, Adeli K: Hepatic insulin resistance, metabolic syndrome and cardiovascular disease. Clin Biochem 2009;42:1331-1346.
22.
Samuel VT, Petersen KF, Shulman GI: Lipid-induced insulin resistance: unravelling the mechanism. Lancet 2010;375:2267-2277.
23.
Fujishiro M, Gotoh Y, Katagiri H, Sakoda H, Ogihara T, Anai M, Onishi Y, Ono H, Abe M, Shojima N, Fukushima Y, Kikuchi M, Oka Y, Asano T: Three mitogen-activated protein kinases inhibit insulin signaling by different mechanisms in 3T3-L1 adipocytes. Mol Endocrinol 2003;17:487-497.
24.
Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, Lee J, Shoelson SE: Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB. Nat Med 2005;11:183-190.
25.
Shah PK: Innate immune pathway links obesity to insulin resistance. Circ Res 2007;100:1531-1533.
26.
Sriwijitkamol A, Christ-Roberts C, Berria R, Eagan P, Pratipanawatr T, DeFronzo RA, Mandarino LJ, Musi N: Reduced skeletal muscle inhibitor of κBβ content is associated with insulin resistance in subjects with type 2 diabetes reversal by exercise training. Diabetes 2006;55:760-767.
27.
Chen W, Goff MR, Kuang H, Chen G: Higher protein kinase C ζ in fatty rat liver and its effect on insulin actions in primary hepatocytes. PLoS One 2015;10:e0121890.
28.
Penn L, Boeing H, Boushey CJ, Dragsted LO, Kaput J, Scalbert A, Welch AA, Mathers JC: Assessment of dietary intake: NuGO symposium report. Genes Nutr 2010;5:205-213.
29.
Keating DP: Transformative role of epigenetics in child development research: commentary on the special section. Child Dev 2016;87:135-142.
30.
Lillycrop KA, Burdge GC: Maternal diet as a modifier of offspring epigenetics. J Dev Orig Health Dis 2015;6:88-95.
31.
Moore TR: Fetal exposure to gestational diabetes contributes to subsequent adult metabolic syndrome. Am J Obstet Gynecol 2010;202:643-649.
32.
Desai M, Beall M, Ross MG: Developmental origins of obesity: programmed adipogenesis. Curr Diab Rep 2013;13:27-33.
33.
Franco J, Fernandes T, Rocha C, Calviño C, Pazos‐Moura C, Lisboa P, Moura E, Trevenzoli I: Maternal high‐fat diet induces obesity and adrenal and thyroid dysfunction in male rat offspring at weaning. J Physiol 2012;590:5503-5518.
34.
Srinivasan M, Katewa SD, Palaniyappan A, Pandya JD, Patel MS: Maternal high-fat diet consumption results in fetal malprogramming predisposing to the onset of metabolic syndrome-like phenotype in adulthood. Am J Physiol Endocrinol Metab 2006;291:E792-E799.
35.
Dickson‐Spillmann M, Siegrist M: Consumers' knowledge of healthy diets and its correlation with dietary behaviour. J Hum Nutr Diet 2011;24:54-60.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.